Equine Healthcare Market Size To Reach $10.40 Billion By 2033

Equine Healthcare Market Growth & Trends

The global equine healthcare market size is expected to reach USD 10.40 billion by 2033, registering a CAGR of 10.93% from 2026 to 2033, according to a new report by Grand View Research, Inc. Increasing product R&D, demand for equine diagnostics, investments by key industry stakeholders, and the rising prevalence of diseases in horses are some of the major factors contributing to the market growth. For instance, in September 2021, the U.S. Department of Agriculture invested around USD 3.0 billion in the animal nutrition and health sector.

The Covid-19 pandemic had a notable impact, particularly on the horse racing/ sports sector. It led to reduced access to equine care services and the cancelation of equine shows. Teaching, training, competitions, events, tourism-related activities, and recreational activities were all discontinued as a result of COVID-19. Horse racing was adversely impacted across the world, along with the demand for horse boarding. Only Sweden continued to hold races within the EU. According to a survey conducted by Hippolia, French Equine Industry Cluster, 68.8% of respondents believed the recovery of the shortfall is impossible, and all equine competitions have been discontinued. A total of USD 385.89 million in sport horse losses were incurred as per estimates. However, the market recovered in 2021 owing to easing lockdown measures and improved access to equine healthcare.

Growing technological advancement, R&D, and initiatives by market players in equine diagnostics are key factors driving the market. For instance, according to a July 2022 article published by the American Veterinary Medical Association, a study was carried out to assess the diagnostic performance of a unique helical fan beam-based CT utilized for imaging horses with clinical head and neck complications. A total of over 120 horses were involved, and the medical records of those who had undergone head or neck CT scans at two university hospitals were examined. Age, sex, breed, the primary complaint, the amount of sedation utilized, the length of the operation, the use of any further diagnostic imaging techniques, the imaging diagnosis, the clinical diagnosis, and any imaging-related problems were all noted. The CT system proved to have short scanning times and reliable utility for regular imaging of horses' teeth and sinuses. 

Furthermore, the rising prevalence of diseases in horses is another factor propelling the market growth. West Nile Virus, for instance, was positively identified in a 10-year-old unvaccinated Quarter Horse stallion in Nevada County who was exhibiting transient fever and neurological symptoms by the California Department of Food and Agriculture in September 2022. This was the 8^th confirmed case of the equine WNV in California in 2022. Other positive cases were identified in six counties: three in Kern, one in Nevada, one in Sacramento, one in San Luis Obispo, one in Tehama, and three in Tulare. This is expected to promote awareness regarding equine diseases while fueling demand for timely vaccination of horses.

 Request a free sample copy or view report summary: Equine Healthcare Market Report

Equine Healthcare Market Report Highlights

• The pharmaceuticals segment held the largest share of 43.49% in 2025 due to its broad clinical relevance, routine usage, and direct link to everyday veterinary decision-making.

• The parasitic infections segment dominated in 2025 and continues to demand significant clinical attention due to its high prevalence and impact on horse health, performance, and welfare.

• The sports/racing activities segment dominated the market in 2025 due to the high clinical intensity and continuous healthcare demand associated with competitive equine use.

• Veterinary hospitals and clinics account for a dominant share in 2025. This channel serves as the primary point for diagnosis, treatment, and ongoing disease management.

• North America equine healthcare market held the largest revenue share of 44.47% in 2025, due to welfare spending, equestrian activities, and advancements in diagnostics and regenerative therapies.

Equine Healthcare Market Segmentation

Grand View Research has segmented the global equine healthcare market report based on product, indication, activity, distribution channel, and region:

Equine Healthcare Product Outlook (Revenue, USD Million, 2021 - 2033)

• Pharmaceuticals

  • Parasiticides

  • Anti-infectives

  • Anti-inflammatory & Analgesics

  • Other Pharmaceuticals

• Vaccines

• Medicinal Feed Additives

• Orthobiologics

• Diagnostics

  • Diagnostic Test Kits

  • Diagnostics Equipment

• Software & Services

  • Practice Management Software

  • Imaging Software

  • Telehealth Software

  • Other Software

• Others

Equine Healthcare Indication Outlook (Revenue, USD Million, 2021 - 2033)

• Musculoskeletal Disorders

• Parasitic Infections

• Equine Herpes Virus

• Equine Viral Arteritis (EVA)

• Equine Influenza

• West Nile Virus

• Tetanus

• Other Indications

Equine Healthcare Activity Outlook (Revenue, USD Million, 2021 - 2033)

• Sports/ Racing

• Recreation

• Other Activities

Equine Healthcare Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)

• Veterinary Hospitals & Clinics

• E-commerce

• Equesterian Facilities

• Other Channels

Equine Healthcare Equine Healthcare Market Regional Outlook (Revenue, USD Million, 2021 - 2033)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

  • Qatar

  • Oman

List of Key Players of Equine Healthcare Market

• Zoetis Services LLC

• Arthrex Inc.

• Dechra

• Boehringer Ingelheim International GmbH

• Ceva Sante Animale

• Heska Corporation

• Merck & Co. Inc

• Esaote SPA

• IDEXX Laboratories, Inc.

• Covetrus Inc.

• Elanco

• Cargill